Recombinant factor VIIA is associated with an improved 24‐hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients

OBJECTIVE: To determine whether recombinant factor VIIa (rFVIIa) is associated with increased survival and/or thromboembolic complications. INTRODUCTION: Uncontrollable hemorrhage is the main cause of early mortality in trauma. rFVIIa has been suggested for the management of refractory hemorrhage. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Nascimento, Bartolomeu, Lin, Yulia, Callum, Jeannie, Reis, Marciano, Pinto, Ruxandra, Rizoli, Sandro
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044583/
https://www.ncbi.nlm.nih.gov/pubmed/21437444
http://dx.doi.org/10.1590/S1807-59322011000100018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044583/
https://www.ncbi.nlm.nih.gov/pubmed/21437444
http://dx.doi.org/10.1590/S1807-59322011000100018

Ejemplares similares